Pictet Asset Management (Switzerland)’s Maravai LifeSciences MRVI Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$135K	Sell	10,855 -3,746	-26%	-$50.6K	﹤0.01%	1807
2023 Q1	$205K	Hold	14,601	–	–	﹤0.01%	1724
2022 Q4	$209K	Buy	+14,601	New	+$230K	﹤0.01%	1716
2022 Q3	–	Sell	-149,696	Closed	-$4.25M	–	1597
2022 Q2	$4.25M	Buy	149,696 +142,192	+1,895%	+$4.5M	0.01%	793
2022 Q1	$265K	Hold	7,504	–	–	﹤0.01%	1427
2021 Q4	$314K	Hold	7,504	–	–	﹤0.01%	1377
2021 Q3	$368K	Buy	+7,504	New	+$366K	﹤0.01%	1324

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s MRVI Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Maravai LifeSciences (MRVI) stake by 26% in Q2 2023, selling an estimated $50.6K and leaving 10,855 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Pictet Asset Management (Switzerland) first reported a position in MRVI in Q3 2021 and has held it in 7 quarters since. The position peaked at $4.25M in Q2 2022. 222 funds tracked by Wall St. Rank hold MRVI as of Q2 2023.

Pictet Asset Management (Switzerland) held 10,855 shares of Maravai LifeSciences worth $135K as of Q2 2023.
Pictet Asset Management (Switzerland) sold 3,746 Maravai LifeSciences shares in Q2 2023, an estimated $50.6K.
Maravai LifeSciences made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1807 holding.
Pictet Asset Management (Switzerland) first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 7 quarters since.
Pictet Asset Management (Switzerland)'s Maravai LifeSciences position peaked at $4.25M in Q2 2022.
222 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.